Clinical Trial Update: Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Pseudoephedrine 30 mg Syrup in Patients Suffering a URTI [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating warming sensation intensity, flavor acceptability, and local tolerability of paracetamol 500 mg + pseudoephedrine 30 mg syrup in patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Respiratory Infection

Drugs mentioned

• Paracetamol 500 mg + Pseudoephedrine 30 mg Syrup (acetaminophen + pseudoephedrine)

Snippet

Sponsor: Novartis | Conditions: Upper Respiratory Infections | Phase 3 | Status: COMPLETED | Results posted: 2013-08-07